NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Prescribing
Greater Glasgow and Clyde Prescribing
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/5965.htm#_5965
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/5967.htm
Restrictions: Only to be prescribed via dermatology clinics.
Prescribing Notes:
A treatment dose of 30mg once daily is recommended and should only be reduced to 10mg once daily if not tolerated.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/201617.htm
Prescribing Notes:
This is not available as a licensed proprietary preparation, but is routinely available as a "special"
Prescribing Notes:
This is not available as a licensed proprietary preparation, but is routinely available as a "special"
Prescribing Notes:
Available in 0.1%, 0.25%, 0.5%, 1% and 2% strengths.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/5984.htm#_5984
Prescribing Notes:
This is not available as a licensed proprietary preparation, but is routinely available as a "special"
Prescribing Notes:
This is not available as a licensed proprietary preparation, but is routinely available as a "special"
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/5990.htm
Restrictions: Restricted to specialist use only. Restricted to hospital use under specialist dermatological supervision.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/5995.htm
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/5943.htm#_5943
Prescribing Notes:
Calcipotriol and betamethasone can be supplied as individual preparations at a significantly reduced cost. A suggested regimen of the separate preparations may be calcipotriol applied in the morning with application of betamethasone at night.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/106478.htm
Restrictions: Restricted to use under specialist dermatological supervision
Prescribing Notes:
Can be used for severe atopic dermatitis or severe psoriasis when conventional therapy has failed.
Prescribe by brand name.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/4783.htm
Restrictions: Restricted to use under specialist dermatological supervision.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/6002.htm
Restrictions: Restricted to initiation by physicians experienced in the management of eczema. It is restricted to the management of moderate eczema on the face and neck of children aged between 2 years and 16 years that has not been controlled by topical steroids or where there is serious risk of important adverse effects from further topical steroid use, particularly irreversible skin atrophy.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/119691.htm
Restrictions: Topical tacrolimus is restricted to initiation and review by a dermatologist.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/119635.htm
Restrictions: Restricted to specialist use only. Use for adults with psoriasis is restricted to initiation and supervision only by specialist physicians in accordance with NICE Technology Appraisal 103. Use for the treatment of chronic severe plaque psoriasis in children and adolescents is restricted to specialist use in patients where the disease: a) is severe as defined by a total Psoriasis Area Severity Index (PASI) of 10 or more and a Dermatology Life Quality Index (DLQI) of more than 10, b) has failed to respond to standard systemic therapies or the patient is intolerant to, or has a contraindication to these treatments, c) Etanercept should be discontinued in patients whose psoriasis has not responded adequately at 12 weeks.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/201652.htm
Restrictions: Restricted to specialist use only. Treatment of severe plaque psoriasis in adults is restricted to specialist use in patients who failed to respond to, or who have a contraindication to, or are intolerant of other systemic therapy including ciclosporin, methotrexate or psoralen ultraviolet A (PUVA) and in accordance with the local approved protocol.
Prescribing Notes:
Infliximab should be prescribed by brand name
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/201653.htm
Restrictions: Restrictions apply as per prescribing notes below.
Prescribing Notes:
Formulary indications:
For use in other indications, see sections 1.5.3 and 10.1.3
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/128230.htm
Restrictions: The treatment of moderate to severe chronic plaque psoriasis in adults patients who failed to respond to or who have a contraindication to, or are intolerant to other systemic therapy including ciclosporin, methotrexate or psoralen and ultraviolet-A light (PUVA) is restricted to specialist use only.
Prescribing Notes:
For other indications please see chapter 10.1.3
Restrictions:
Restricted to specialist use in patients who have failed to respond to standard systemic therapies (including ciclosporin, methotrexate and phototherapy), are intolerant to, or have a contra-indication to these treatments
Restrictions: Restricted to specialist use only. Restricted to use under specialist dermatological supervision.
BNF Link: http://bnf.org/bnf/bnf/current/6002.htm
Restrictions: Use for moderate to severe plaque psoriasis in adults is restricted to specialist use in patients who have failed to respond to standard systemic therapies (including ciclosporin, methotrexate and phototherapy), are intolerant to or have contraindications to these treatments.
Restrictions:
Restricted to specialist use in accordance with the prescribing notes below.
Prescribing Notes:
Psoriasis in adults:
Psoriasis in adolescents:
For use in psoriatic arthritis see section 10.1.3